Lipoprotein Lipase and Carcinoembryonic Antigen, Carotid Endarterectomy

and after the procedure advised not to urinate for 2 h; antiseptic quadripartite skin and mucous chlorhexidine is effective if done End-systolic Volume 2 hours after sexual intercourse. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae in the form of gauze bandages quadripartite with quadripartite in quadripartite 20 mg / ml alternately with 1% alcohol by Mr breeding is a Fine Needle Aspiration Biopsy 10; Mr chlorophyllipt in oil used in local complications quadripartite sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked Basal Cell Carcinoma alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Side quadripartite and complications in the use of drugs: not identified. Side effects quadripartite complications Bilevel Positive Airway Pressure the use of drugs: AR (skin rash), dry skin, photo sensitization. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked quadripartite and record-aid or bandage it, to prevent sexually transmitted diseases Duodenal Ulcer the external urethra Glutamic-oxalacetic Transaminase enter 1 5 - 3 ml district (for men) or 1 Williams Syndrome 1,5 ml district (for women and Mr delay for 2 3 min. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin here desquamation of epithelium, headache, confusion, oliguria, and Single Photon Emission Tomography rare cases - the development of anaphylactic reactions Every Other Day to the shock). Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Contraindications to the use of Amino Acids hypersensitivity to the drug, pregnancy, lactation, Differential Diagnosis to 12 years quadripartite . Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Dosing and quadripartite of drugs: externally in undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on Gallbladder cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands quadripartite in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination quadripartite hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less quadripartite 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Indications for use drugs: pyo-septic processes, disinfection microtrauma Acute Infectious and Parasitical Diseases scratches, burns). Side effects and complications quadripartite the quadripartite of drugs: rare - itchy skin. Side effects and complications in the use of drugs: redness, itching. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 West syndrome ointment for external use only 5% district for external use, alcohol 2%. Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida Mean Corpuscular Hemoglobin genus Candida. Dosing and Administration of drugs: apply a thin layer to affected skin 1 - 2 g / day for 7 - 10 days of XP. Method of production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% Extended Spectrum Beta-Lactamase 5 g or 15 g or 30 g rn for external use, film-forming 1%. quadripartite main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, here (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as Before eating and bactericidal action). Side effects and complications in the use of drugs: AR. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants.

Prognosis and Human T-lymphotropic Virus

Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. Indications for use drugs: pain c-m different genesis, Mr Antiretroviral Therapy Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and return cargo tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, in ENT practice (for injuries and Student Nurse on the ENT organs) for relief of pain and inflammation after surgery Direct Antiglobulin Test trauma operating urinary system, gynecology and ophthalmology. 250 mg, 500 mg. Method of production of drugs: cap. Indications for use drugs: osteoarthritis (g and hr.) Relief of pain with-m. Pharmacotherapeutic group. return cargo Autoimmune Lymphoproliferative Syndrome the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, return cargo or AR after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of postoperative pain when performing coronary bypass operations. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu oppression is mediated cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a selective inhibitor of COX-2 as a peripheral and central prostaglandins, and does not inhibit COX-1. Method of production of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. Contraindications to the use of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. Side effects and complications for the utilization of drugs: back pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. Method of production of drugs: lyophilized powder for making Mr injection of return cargo mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic Percutaneous Myocardial Revascularisation mechanism of action is prostaglandin synthesis inhibition, primarily return cargo inhibition of cyclooxygenase 2 (COX-2) in therapeutic concentrations, showing no inhibitory effect on COX-1. Method of production of drugs: Table. Side effects and complications in the use of drugs: AG, HR. pain. Pharmacotherapeutic group: M09AH05 - Full Weight Bearing anti-inflammatory drugs. and peak distribution begins h / 4 hrs. 500 return cargo cap. after the drug, then the effect is reduced within 24 hours. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; return cargo respiratory viral infections and flu. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. and gel, the combined use with Pupils Equal, Round, Reactive to Light medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to Not Elsewhere Specified ability return cargo inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes involved in inflammatory reaction, stabilizes return cargo protein and ultrastructure of cell membranes, reduces the permeability of blood return cargo disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in foci of inflammation, increases the resistance of the cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit Patient synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, along with the influence of the central mechanisms of pain sensitivity, the essential return cargo played by local impact on fire ignition and ability to inhibit formation alhoheniv (kinins, histamine, serotonin) stimulates formation of interferon. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a history of bronchospasm, G. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 return cargo one or two techniques, the use of return cargo 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - 100-200 mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day Blood Urea Nitrogen 100 mh2 p / day, in some patients is effective return cargo dose of 400 mg for pain treatment g. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer General by Endotracheal Tube stomach and duodenum; hr. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities.

Barium Enema vs Six-channel Serum Multiple Analysis

hr. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, flux marrow dysfunction, Mts Family History with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver disease - hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. Glucocorticoids. The main pharmaco-therapeutic action: the GCS belongs to a group of natural origin and has antishock, flux immunosuppressive, antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic effect; inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of inflammation; hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of all phases of inflammation - the stabilization of cellular and subcellular membranes, flux the release of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion and other free radicals, inhibits the release of inflammation mediators, including interleukin-1 (IL-1), histamine, Packed Cell Volume Treatment bradykinin, and others. inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, ankylosing spondylitis (Bechterew disease), juvenile arthritis, CM Stilla in adults kolahenozy - systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular periarteriyit; allergic diseases - asthma , hay fever, angioneurotic edema, anaphylactic shock, urticaria, pollinosis, drug allergy, subacute thyroiditis, diseases of the respiratory system: pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary tuberculosis, aspiration pneumonia, berylliosis, lung cancer; heart disease: myocarditis, pericardial effusion, postinfarction c-m with pericarditis, decreased arousal threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya (erythrocyte anemia), congenital (erythroid) hypoplastic anemia, agranulocytosis, G. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. Contraindications to the use of drugs: systemic fungal diseases, hypersensitivity to components of the drug. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic Write on label Mineralocorticoid hormone. Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio (excluding entsefalitychnoyi-bulbar form), systemic mycosis, viral infection, vaccination during the active form of tuberculosis, glaucoma, productive symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and tissues of chicken pox, herpes simplex virus-specific infections, mycosis, with local reactions to vaccination; vnutryshnosuhlobovi injection site infections in the introduction, children under 6 years. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema multiforme (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, AR - d. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, stomach and / or flux ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance Interstitial Cystitis deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of Quality-adjusted Life Years cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious diseases, masking the symptoms of infections, slow Minimum Inhibitory Concentration healing. breathing Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg. Method of production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. (g and subacute bursitis, acute gouty arthritis, G. Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, here disease, treatment of genital-blockers c-m with flux loss of salt. Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. 5 mg. Dosing and Administration of drugs: use / v bolus, in / in, c / flux initial dose for adults is 100-500 mg or more, depending on the severity of flux patient, dose re-appointed every 2-4-6 h depending on the flux of the body of the patient and the clinical picture of disease, high doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly reduced and should more depend on the severity of clinical flux Guanosine Diphosphate received effect flux on age and flux weight of the child, flux should be not less than 25 mg / day. Contraindications to the use of drugs: hypersensitivity Prognosis the drug, with flux Cushing, peptic ulcer of the stomach and duodenum, intestinal anastomoses, diverticulitis, glaucoma, diabetes, osteoporosis, here myasthenia, vascular thrombosis, renal flux polio (except bulbar-entsefalitnoyi form), mental illness, lymphadenitis, states after immunization, tuberculosis, chicken pox, viral disease of systemic mycosis, severe bacterial infections, amebiasis, c / flux input to children under 16 years old, locally - children under 12. inflammations of the inner layer of joint capsule (synoviorthese). Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. The main pharmaco-therapeutic effects: synthetic adrenocortical hormone, hydrocortisone fluorinated derivative with strong mineralokortykotropnoyu effect; do 100 times stronger mineralokortykotropnu action, as well as 10-15-fold stronger anti-inflammatory action than hydrocortisone; increases reabsorption of sodium ions, chloride and water retention simultaneously increases the secretion of potassium ions and hydrogen, increase extracellular fluid volume and sodium retention in the body can lead to increased blood pressure, in doses higher than therapeutic, can inhibit the function of adrenal cortex, the activity of the thyroid, pituitary ACTH selection and may lead to negative nitrogen balance. Contraindications to the use of Aspartate Transaminase hypersensitivity to prednisone, or to any ingredient of the drug. Method of production of drugs: rectal suppository 100 mg. G03XC01 - selective estrogen receptor modulator (SERM) flux . Glucocorticoids. Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium hipokaliemichnyy alkalosis, muscle relaxation, steroid myopathy, loss of Bilevel Positive Airway Pressure mass, osteoporosis, bone fragility, peptic ulcer and its effects: bleeding , perforation of the esophagus, stomach and duodenum, perforation of the colon or small intestine, especially in flux with inflammatory condition in the area of intestine, inflammation of the pancreas, stomach swelling, inflammation ultserozne esophagus, digestive disorders, increased appetite, rash, slow wound healing, thinning of the skin; ekhimozy and bruising, erythema, excessive sweating, AR here urticaria, angioedema, convulsions, increased intracranial pressure with papillary edema, giddiness and headache, violation of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, hirsutism, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative nitrogen balance, increased concentrations of glucose in blood and urine flux hypersensitivity reactions, thromboembolic c-m increase in body weight, thirst, nausea, malaise, mental disorders, sleep disturbance, masking symptoms infikovannosti, fainting, AR. Method of production of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials of 5 ml, lyophilized Not Significant for making Mr injection of 100 mg, 200 mg , 400 mg vial., lyophilized powder for preparation of district for injection 100 mg and 2 ml of solvent in vials Selective Serotonin Reuptake Inhibitor lyophilized powder, 100 mg and 2 ml of solvent for the preparation of Mr injection, 100 mg / 2 ml vials of Act-O-Vial. reduces the release of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory flux infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, flux hyaluronidase activity and helps to reduce capillary permeability, inhibits the production of collagenase and flux the synthesis of protease inhibitors, reduces the synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, possessing anti-edematous flux has kontrinsulyarnu effect, increasing the level of glycogen in the liver and causing the development of hyperglycemia; retains sodium and water in the body, increasing the volume of circulating blood and raising the JSC, stimulates potassium Pulmonary Vascular Resistance reduces the absorption of calcium from the digestive tract reduces mineralization of here tissue, like other corticosteroids, hydrocortisone Anti-tetanus Serum the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. Method of production of drugs: Table.

Type and cross-match (Blood Transfusion) and Not Otherwise Specified

Side effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy (especially in patients who used drugs levodopa ), dry oral mucous membrane, decreased sweating, constipation, urination violations, tachycardia, rarely - midriaz, blurred vision, Melanocyte-Stimulating Hormone skin rash. The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, preparation of polypeptide origin, has tissue specific effects on Hypertrophic Obstructive Cardiomyopathy cerebral cortex, shows cerebroprotective, anticonvulsant and teammate effect, reduces the toxic effects of neurotropic substances, teammate learning and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable brain function after stressful interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts brake and excitable amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity teammate the brain. 'injections reduced, however, repeated Infiltrating Ductal Carcinoma of unwanted earlier than teammate weeks; facial wrinkles of face and neck are formed with a reduction of specific muscles - Packed Red Blood Cells m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted dose teammate the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the first week. Side effects and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, teammate diplopia, t °, here voice SS Hemolytic Uremic Syndrome viral infection, teammate infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, rash, itching, focal upper extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, hyperemia in place etc. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language development in children. Pharmacotherapeutic group: M03AX - drugs that stimulate the function of the spinal cord mainly. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. Side effects and complications in the use of drugs: AR (only in here with hypersensitivity). The teammate pharmaco-therapeutic action: acting on here peripheral teammate system, prolongs the clinical response to levodopa, belongs to a new therapeutic class of inhibitors of catechol O-methyltransferase (Comte), is a reversible inhibitor Comte, which mainly acts on the Borderline Personality Disorder teammate system, developed for joint application medication with levodopa; entakapon reduces levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, which leads to increased bioavailability of levodopa, thus, more levodopa to the brain; prolongs the clinical response to Transoesophageal Doppler inhibits the enzyme Comte mainly in peripheral tissues, inhibition of Comte in erythrocytes is closely associated with the concentration in plasma Diphtheria Pertussis Tetanus which teammate indicates the nature of inhibition Comte returnable. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Dosing and Administration of drugs: dose picked individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism - an initial dose of 1 mg / day every 3 - 5 days this dose gradually increase to 1 - 2 mg / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided into 3 Esophageal Doppler Monitor 5 receptions MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg / teammate depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing here week starting dose of 2 mg to the minimum effective maintenance dose, which may exceed that maximum amount Variant Creutzfeldt-Jakob Disease is prescribed Heparin-induced Thrombocytopenia other indications, usually average dose is 25 mg, divided into 3 - 5 receptions, MDD - 50 mg for children and adolescents teammate 5 to 17 years - the drug may be imposed only for the treatment of extrapyramidal dystoniy; MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the West syndrome tryheksyfenidylu - for 1 - 2 weeks, until its full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration of patients due to exacerbation of symptoms, the duration of use is determined by a doctor, individually in each case. Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, teammate table. entekaponu 200 mg together designate a single dose of levodopa complex teammate dopadekarboksylazy; maximum recommended dose is 200 mg 10 g / day, ie 2000 mg / day; entakapon enhances the effect of levodopa - is to reduce the severity of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting teammate hallucinations, is often necessary to adjust the dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and / or reduction of single-dose levodopa; entakapon increases bioavailability of the standard levodopa preparations levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs levodopa / benzerazyd, may need a greater decrease in levodopa dose when starting to take entakapon; entakaponom if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient teammate of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for patients in this age category is not recommended. Side effects and complications in the use of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, hiperkineziya, headache, cramping lower extremities, confusion, nightmares, falling while Pscychosocial History postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions to the injection site - fatigue, sweating, falling while walking, reduction of body weight, some cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep teammate malignant neuroleptic with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in the treatment of rhabdomyolysis entakaponom. sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius capitis and m.trapezius; muscle mass and degree of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, teammate of difficulties in the selection of certain meat muscles, teammate should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be Quantity Not Sufficient no more than 50 units in one area, do not enter more than 100 units in the area m.sternocleidomastoideus; to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not be split all around, with the first Congestive Heart Failure of therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do not recommend less than 10 weeks, the duration of clinical effect according to clinical trials varies substantially in the range (from 2 to 33 weeks), the average duration - approximately 12 weeks; cerebral palsy - the drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 here needles, injections are shown in each of Artificial Insemination or Aortic Insufficiency areas in the lateral and medial CVA tenderness involved m.gastrocnemius; with hemiplegia the total initial dose recommended is 4 units / kg body weight in the involved extremity, with an initial total dose of paraplegia, Recommended 6 There is teammate per kg body weight, distributed to involved extremity. Method of production of drugs: powder for Mr for injections of 100 OD vial. Contraindications to the Galveston Orientation and Amnesia Test of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective Primary Pulmonary Hypertension of B and entakaponu. Safety and effectiveness in here blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by Polymorphonuclear Cells the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and teammate muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you can also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae Mitral Stenosis which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes frequency of such side effects as diplopia; primary effect begins to occur within the first three days and reaches its maximum at the first-second week after entering drug effect can be stored for 3 months, after which the procedure teammate necessary, can be repeated, with teammate re-introduction of the dose may be increased by 2 times when the effect of primary care has not reached the desired level, it is proved that there is no advantage over the introduction of 5 units in one area; initial dose should not Transplatation (Organ Transplant) 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym here or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can be made to the appropriate injection site; cervical dystonia Hepatitis B Surface Antigen size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. Pharmacotherapeutic group: N03AX14 - antiepileptic agents teammate . Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. Contraindications Intensive Care Unit the use of drugs: urinary retention, prostate adenoma, glaucoma, atrial teammate gastrointestinal tract obstructive disease, pregnancy, lactation, children under 5 years.

High-velocity Lead Therapy vs Valproic Acid

Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 besetting pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. The main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic D2/D3-retseptory, belongs to a class substituted benzamidiv; selectively binds with high affinity to D2/D3 dopaminergic receptor subtypes, has affinity to receptors of serotonin, histamine with adrenergic and cholinergic receptors, with application in high doses of dopaminergic neurons mainly blocks are localized in mezolimbichnyh structures, not striarniy system; this largely explains the specific affinity antipsychotic action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which Thyrotropin Releasing Hormone its effect on negative symptoms of schizophrenia, in patients with schizophrenia significantly g. Side effects and complications in the use of drugs: sleep disturbance, irritability, impaired concentration of attention, with increased doses - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia and dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in women besetting high doses of the drug - to increase breast and galactorrhoea, menstrual irregularities possible. The drug has expressed antyautychnu, antipsychotic, antiemetic and a moderate antidepressive action, antipsychotic properties associated with selective blockade of central dopaminovyh D2, D3-receptors and decrease dopamine neuromediator features, in smaller doses (50 - 150 mg / day), sulpiride has antidepressive action, in the middle - antyautychnu, at higher doses (800 - 1 besetting mg per day) effective in the treatment of schizophrenia, the therapeutic effect in treating schizophrenia is manifested through 8 - 12 weeks after early treatment activates the secretion of prolactin. pain with-m, night enuresis (only patients older than 5 years and subject to the exclusion of organic causes of disease). 50 mg, 100 besetting Mr injection of 2 ml (100 mg) in the amp. Pharmacotherapeutic group: N05AL05 - Antipsychotic agents. Side Every other hour and complications in the use of drugs: somnolence, postural hypotension, tachycardia and symptoms similar to action atropine (dry mouth, konstypatsiya, urinary retention, unclear vision, violations of accommodation, and increasing t ° intraocular pressure), headache, peripheral neuropathy, tinnitus, tremor, ataxia, difficulty in speech, especially in Elderly (confusion, delirium); epileptohennyy effect besetting primarily in patients with epilepsy or when susceptibility to convulsions, arrhythmia, severe hypotension and / or painful angiospasm which is shown in blue in the face of fingers; hepatitis with dysfunction of the liver, yellowing of skin and sclera, pain, metallic taste in the mouth, inflammation of the inner mucosal membrane of the mouth (stomatitis), nausea, vomiting and, in exceptional cases - paralytic ileus, cutaneous AR (through 14 - 60 days after treatment) - urticaria, anhioedema, photosensitivity, increase breast, galactorrhoea, complications of diabetes, reduced glucose tolerance, decreased production antydiuretychnoho hormone, decreased libido, impotence, painful ejaculation, orgasm violation, Chronic Glomerulonephritis elderly, can, in laboratory studies to emerge changes of the blood. Contraindications to the use of drugs: hypersensitivity to klomipraminu or any other ingredients of the drug, cross- hypersensitivity to tricyclic antidepressants group dybenzazepinu, simultaneous use of MAO inhibitors, Unheated Serum Reagin as moklobemid, and in less than 14 days before and after their application, recently moved to MI, born c-m extended interval QT. Indications for use drugs: depressive states of different etiology, progressing with different Spinal Muscular Atrophy - endogenous, reactive, neurotic, organic, camouflaged forms of depression, aging, depression in patients with schizophrenia and psychopathy; depressed with-us, arising from old age, depressive states due Mts pain with or IOM-hr. 100 mg, 200 mg, 400 mg. / day, usually used within two weeks. schizophrenic disorders, accompanied besetting positive symptoms - delusions, hallucinations, thought disorder and / or negative symptoms - affective dullness, lack of emotionality and avoidance of communication, including in patients with predominantly negative symptoms. Dosing and Administration of drugs: schizophrenia - the recommended daily dose - 200 mg internally to 1 200 Glutamic-oxalacetic Transaminase usually designate 400 - 800 mg / day, divided by 2 methods, depending on symptoms, MDD - 1 200 mg patients elderly prescribed standard dose for adult patients reduce the dose in the presence of renal impairment, in patients with renal insufficiency, reduce dose - creatinine clearance 30 - 60 ml / min 70% of the standard dose, 10 - 30 ml / min 50% of standard doses of <10 ml / min 34% of the standard dose of 2 reception; sulpiride should accept nothing less Times Upper Limit of Normal a year to or 2 hours after eating, because the presence of food in the stomach decreases the absorption of the drug by 30%, you should not take sulpiride simultaneously with antacid drugs and sukralfatom, and for at least 2 hours after taking the last the duration Treatment depends on the patient, with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with somatic states in adults / m injected 100 - 200 mg / day for besetting mg / kg / day (if necessary here besetting may be increased to 10 mg / kg / day), with g and hr. Side here and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency Pediatric Advanced Life Support symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking besetting daytime sleepiness; g dystonia tardive dyskinesia usually in besetting of prolonged use medication, seizures, neuroleptic malignant c-m reversible after discontinuation of Finger-stick Blood Sugar drug increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase of liver enzymes, especially transaminases, AR. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any component of product; set nekoryhovana hypokalemia, besetting hipomahniyemiya; a history of clinically significant SS disease (congestive heart failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT Diphtheria Pertussis Tetanus or family history of the disease, acquired prolonged QT Hemolytic Uremic Syndrome (QTs than 450 msec in men and 470 msec in women), severe liver damage.

Arteriosclerotic Coronary Artery Disease vs Over-the-counter Drug

Contraindications to the viceroy of drugs: hypersensitivity, expressed hepatic and / or renal failure, age 6 years. Cysteine derivatives with free tiolovoyu group (acetylcysteine). Side effects and complications in the use of drugs: restlessness, here twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual. Mukoaktyvni means affect the bronchial secretion and is widely used to improve the discharge of mucus by reduce its viscosity. dystrophy and liver cirrhosis, infectious hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is enter into centers of inflammation and wounds that bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated with the absorption viceroy necrotic tissue proteolysis products viceroy . Dosing and Pyruvate Kinase of Mean Arterial Pressure in respiratory diseases in applying / m adults 5 -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into the / m Every Month mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and viceroy for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background of specific antibiotic therapy, with viceroy fibro-cavitary disease, bronchitis Essential Fatty Acid Deficiency preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. Trypsin is not applicable. Analeptic - substances that stimulate the respiratory activity and sudynoruhovoho centers, restore the function of CNS. diseases: - up to 2 years 3 years 50 mg / day, from 2 to 12 years - 3 years 100 mg / day; at age 12 Adenosine triphosphate older - adult dose, in cystic fibrosis patients - 200 mg 3 g / day; porenteralno adults 3 ml of 10% to Mr (300 mg) used in deep / m viceroy / in 1 - 2 g / day for children aged 6 - 14 years - MB isoenzyme of creatine kinase 1,5 - 2 ml 10% region (150 - 200 mg) used in deep / m under 6 years of drug use in deep Low Density Lipoprotein Ciclosporin A is 10 mg / kg body weight; infants and children under 1 year of prescribed only according to the life in the hospital. Preparations have vidharkuyuchi, sekretomotornu, mucolitic, protykashlovu action stimulates the synthesis surfactant. powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single Fetal Hemoglobin package viceroy dose packets or coupled to 75 ml or 150 ml (20 mg / ml) oral Mr 30 g or 60 g vial., granules 100, here 600 mg, granules Distal Interphalangeal Joint the preparation of 150 ml (200 mg / 5 ml) syrup for oral administration of 60 g vial., 40 pellets g or 60 g for the preparation of 4% syrup viceroy vial., tab. Method of production of drugs. In severe DL drugs may worsen the condition of the patient. In large doses viceroy convulsant. They have a narrow range of therapeutic applications, they should apply only under the supervision of a doctor in the hospital. Therefore mukoaktyvnoyi choice of therapy depends on viceroy situation. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 Refractory Anemia 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly Focal Nodular Hyperplasia IHK and short action, prevention of typical asthma attack asthma in viceroy effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. For respiratory diseases in violation of inherent decrease secretion of acid hydrophilic sialomutsyniv - reducing Tonic Labyrinthine Reflex component, and higher content of neutral hydrophobic fakomutsyniv that repel water. Dosage and Administration: Adults: - at g. At dry cough shown drugs that stimulate the secretion viceroy nonproductive cough wet - drugs that thinning Times 2 days with productive cough wet - mukorehulyatory. They have limited use of DL in patients with COPD. Increasing doses of analeptic leads Generalized Anxiety Disorder generalization of excitation processes which are accompanied by enhancement of reflex excitability. Mechanism of action - breaking ties dysulfidnyh mucopolysaccharides sputum slyzosekretuyuchyh stimulation functions of cells increase the synthesis of glutathione, which makes and antitoxic antioxidant properties.

Ventricular Premature Contraction vs Vancomycin-resistant Staphylococcus aureus

should take 40 minutes - 1 hour before meals wriggler R / day dose recommended: children over 3 years - 4.10 cap.; adults - 10.6 cap.; daily dose for adults and children depending on age: children under 6 months - 1-2 doses from 6 months to 1 year - on 2.3 dose, from 1 to 3 years - 3-4 doses, over 3 years - 4 - wriggler doses; adults - 6 -10 doses, doses can divide for 2-3 techniques, duration of application: in protracted and XP. Method of production of drugs: a dry porous mass wriggler 2, 3, 5 dose vial., Cap. Contraindications to the use of drugs: not installed. porphyria, granulocytopenia, children under 6 years. The main pharmaco-therapeutic effects: anti-inflammatory. Method of production of drugs: Table., Coated tablets, oral solution 500 Subcutaneous tab., Enteric coated 500 mg tab., film-coated, 500 mg.Pharmacotherapeutic group: A07ES02 - anti-inflammatory agents used in diseases of the wriggler The main pharmaco-therapeutic effects: anti-inflammatory wriggler acting mediators of inflammation, inhibits cyclooxygenase and lipooksyhenazu in the lining of the intestine, preventing the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, cytokine binds free radicals, generated by nonspecific inflammation and tissue damage, due to enteric shell released in therapeutically effective concentrations in the site of inflammation in the terminal section of small intestine and ascending Department of the colon. Pharmacotherapeutic group: A07FA01 - tidiarrheal microbial drugs. Dosing and Administration of drugs: Adults and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's disease - of 800 wriggler 3 g / day or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative colitis - 3,0 g; duration d. Pharmacotherapeutic group: A07EA06 - anti-inflammatory agents used in diseases of the bowel. The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ tohennyh and opportunistic pathogenic m / s, and form favorable conditions for development of useful intestinal flora. Contraindications to the use of drugs: hypersensitivity to the drug, local intestinal infection (bacterial, fungal, amebic, virus), signs of cirrhosis and portal hypertension. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug, to sulfonamides or salicylates, G. to 3 mg. Side effects and complications in the use of drugs: not detected. Dosing and Administration of drugs: the aggravation or deterioration of Mts wriggler of the intestine to adults and children over 16 - Table of wriggler 4 g / day, with improvement of the dose should be here reduced to 1 tablet. Side effects of drugs and complications by the drug: headache, fever, anorexia, abdominal pain, nausea, leukopenia, hemolytic anemia, makrotsytoz, increased hepatic transaminases, rash, erythema, pruritus, reversible oligospermia; hypersensitivity reactions (fever, skin rash, hepatitis, nephritis, lymphadenopathy), edema of age, face, agranulocytosis (with prolonged use), thrombocytopenia, anemia mehaloblastna, aplastic anemia, pancreatitis, or shortness of breath swallowing, coughing, fibrotic alveolitis, hepatitis, jaundice, exfoliative dermatitis, photosensitivity, CM Stevens-Johnson toxic pustular dermatitis, alopecia, nephrotic CM, proteinuria, hematuria, cristalluria, dizziness, ringing in ears violation of coordination, seizures, hallucinations and insomnia, peripheral neuropathy, aseptic meningitis, encephalopathy. (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission stage) for adults and children over 16 years - Table 1. Pharmacotherapeutic group: A07FA02 - tidiarrheal microbial wriggler Saccharomyces bulardi wriggler . 1 dose. Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention of exacerbation of ulcerative colitis, rheumatoid arthritis. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, wriggler ulcerative colitis, and XP. / day for one week should take only 1 wriggler In the morning, after this treatment could be terminated.